Study protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a prospective, randomized, open-label, multicenter phase II trial investigating the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer.
Saved in:
| Title: | Study protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a prospective, randomized, open-label, multicenter phase II trial investigating the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer. |
|---|---|
| Authors: | Sommerhäuser, G.1 (AUTHOR), Kurreck, A.1 (AUTHOR), Stintzing, S.1,2 (AUTHOR), Heinemann, V.2,3 (AUTHOR), von Weikersthal, L. Fischer4 (AUTHOR), Dechow, T.5 (AUTHOR), Kaiser, F.6 (AUTHOR), Karthaus, M.7 (AUTHOR), Schwaner, I.8 (AUTHOR), Fuchs, M.9 (AUTHOR), König, A.10 (AUTHOR), Roderburg, C.11 (AUTHOR), Hoyer, I.1 (AUTHOR), Quante, M.12 (AUTHOR), Kiani, A.13 (AUTHOR), Fruehauf, S.14 (AUTHOR), Müller, L.15 (AUTHOR), Reinacher-Schick, A.16 (AUTHOR), Ettrich, T. J.17 (AUTHOR), Stahler, A.1 (AUTHOR) |
| Source: | BMC Cancer. 7/27/2022, Vol. 22 Issue 1, p1-14. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14712407 |
|---|---|
| DOI: | 10.1186/s12885-022-09892-8 |
